The Bristlemoon Global Fund achieved an 11.9 percent cumulative return since inception despite recent quarterly volatility.

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Multiexperience Development Platforms Market by Component (Platforms, Services), Deployment Type (On-premises, Cloud), ...